Sep 21, 2018 - $10,455,572. $17,408,785. Total Direct Costs. $23,667,766. $47,397,781. $66,170,586. $37,765,319. $71,375,965. $97,506,280. $88,861,224.
CORRECTION
Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico Ana Patricia Ortiz, Karen J. Ortiz-Ortiz, Moraima Rı´os, Jose´ Laborde, Amit Kulkarni, Matthew Pillsbury, Andreas Lauschke, Homero A. Monsanto, Cecile Marques-Goyco
There is an error in the third sentence of the second paragraph of the Introduction. The correct sentence is: “In Puerto Rico, cancer was the second leading cause of death by 2010 [8], and cervical cancer accounts for 3.9% of all cancer cases [9].” There are errors in Table 1. The numbers from the 34%/13% scenario are repeated for the 50%/40% and 80%/64% scenarios. In addition, I the 80%/64% scenario, the years have an inverted order. Please see the corrected Table 1 here.
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
OPEN ACCESS Citation: Ortiz AP, Ortiz-Ortiz KJ, Rı´os M, Laborde J, Kulkarni A, Pillsbury M, et al. (2018) Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico. PLoS ONE 13(9): e0204759. https://doi.org/ 10.1371/journal.pone.0204759 Published: September 21, 2018 Copyright: © 2018 Ortiz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | https://doi.org/10.1371/journal.pone.0204759 September 21, 2018
1/2
Table 1. Estimated cumulative incidence costs avoided since HPV4 vaccination program started, by vaccination scenario. HPV Disease
Vaccination Scenario (34% Female/13% Male) 25 years
50 years
Vaccination Scenario (50% Female/40% Male)
100 years
25 years
50 years
100 years
Genital warts-female
$8,671,954
$14,257,263
$18,123,487
$12,814,209
$20,640,587
$26,038,578
Genital warts-male
$8,108,461
$13,440,910
$17,091,889
$16,223,314
$26,604,903
$33,770,465
CIN1
$841,749
$1,975,720
$2,863,853
$1,151,140
$2,573,883
$3,687,742
CIN2/3
$4,830,393
$13,375,935
$20,551,689
$6,053,998
$16,289,155
$24,930,480
Cervical cancer
$1,215,209
$4,347,953
$7,539,668
$1,522,658
$5,267,437
Total Direct Costs
$23,667,766
$47,397,781
$66,170,586
$37,765,319
$71,375,965
Vaccination Scenario (80% Female/64% Male) 25 years
50 years
100 years
$51,246,695
$64,843,815
$37,975,475
$62,669,838
$79,764,797
$2,771,264
$5,765,318
$8,071,479
$13,071,331
$32,275,160
$48,333,370
$9,079,015
$3,365,007
$10,455,572
$17,408,785
$97,506,280
$88,861,224
$162,412,583
$218,422,246
$31,678,147
https://doi.org/10.1371/journal.pone.0204759.t001
Reference 1.
Ortiz AP, Ortiz-Ortiz KJ, Rı´os M, Laborde J, Kulkarni A, Pillsbury M, et al. (2017) Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico. PLoS ONE 12(11): e0184540. https://doi.org/10.1371/journal.pone.0184540 PMID: 29190725
PLOS ONE | https://doi.org/10.1371/journal.pone.0204759 September 21, 2018
2/2
